As somebody that works in the biotech/health space, this page is not that exciting?

The bottleneck in drug development is not discovery; we have to test more hypotheses more efficiently, not generate more hypotheses. You don't need a product like foundry to have reproducibility or share pipeline templates; there are already free, scripting-language-agnostic workflow tools.

Healthcare use of foundry != biotech/bioinformatics use of foundry?

A former work colleague works in health ontologies. They are complicated and include EMT and ward staff using terms of art with inverse meaning.

Perhaps I misread your intent, belittling complexity in somebody else's information space (eg a function of multiple parallel legacy systems and organisational change) seems unhelpful. You weren't excited, maybe people on the management and health economics side were?